| Prednisolone or pentoxifylline for alcoholic hepatitis MR Thursz, P Richardson, M Allison, A Austin, M Bowers, CP Day, ... New England Journal of Medicine 372 (17), 1619-1628, 2015 | 800 | 2015 |
| Multigenerational epigenetic adaptation of the hepatic wound-healing response M Zeybel, T Hardy, YK Wong, JC Mathers, CR Fox, A Gackowska, ... Nature medicine 18 (9), 1369-1377, 2012 | 311 | 2012 |
| Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study GJ Webb, T Marjot, JA Cook, C Aloman, MJ Armstrong, EJ Brenner, ... The Lancet Gastroenterology & Hepatology 5 (11), 1008-1016, 2020 | 251 | 2020 |
| Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease T Hardy, M Zeybel, CP Day, C Dipper, S Masson, S McPherson, ... Gut 66 (7), 1321-1328, 2017 | 208 | 2017 |
| In patients with severe alcoholic hepatitis, prednisolone increases susceptibility to infection and infection-related mortality, and Is associated with high circulating levels … N Vergis, SR Atkinson, S Knapp, J Maurice, M Allison, A Austin, ... Gastroenterology 152 (5), 1068-1077. e4, 2017 | 177 | 2017 |
| A TLR2/S100A9/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse A Moles, L Murphy, CL Wilson, JB Chakraborty, C Fox, EJ Park, J Mann, ... Journal of hepatology 60 (4), 782-791, 2014 | 161 | 2014 |
| Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease M Zeybel, T Hardy, SM Robinson, C Fox, QM Anstee, T Ness, S Masson, ... Clinical epigenetics 7 (1), 1-11, 2015 | 159 | 2015 |
| The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease M Boyle, S Masson, QM Anstee Journal of hepatology 68 (2), 251-267, 2018 | 151 | 2018 |
| Potential of hematopoietic stem cell therapy in hepatology: a critical review S Masson, DJ Harrison, JN Plevris, PN Newsome Stem cells 22 (6), 897-907, 2004 | 141 | 2004 |
| Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experience S Masson, HA Mardini, JD Rose, CO Record QJM: An International Journal of Medicine 101 (6), 493-501, 2008 | 102 | 2008 |
| The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury L Barbier-Torres, P Iruzubieta, D Fernández-Ramos, TC Delgado, ... Nature communications 8 (1), 1-11, 2017 | 94 | 2017 |
| Natural history of histologically proven alcohol-related liver disease: A systematic review R Parker, GP Aithal, U Becker, D Gleeson, S Masson, JI Wyatt, IA Rowe, ... Journal of hepatology 71 (3), 586-593, 2019 | 93 | 2019 |
| Application of prognostic scores in the STOPAH trial: Discriminant function is no longer the optimal scoring system in alcoholic hepatitis EH Forrest, SR Atkinson, P Richardson, S Masson, S Ryder, MR Thursz, ... Journal of hepatology 68 (3), 511-518, 2018 | 92 | 2018 |
| Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trial E Forrest, J Mellor, L Stanton, M Bowers, P Ryder, A Austin, C Day, ... Trials 14 (1), 262, 2013 | 84 | 2013 |
| The degree of hepatic steatosis associates with impaired cardiac and autonomic function D Houghton, P Zalewski, K Hallsworth, S Cassidy, C Thoma, L Avery, ... Journal of hepatology 70 (6), 1203-1213, 2019 | 71 | 2019 |
| Baseline neutrophil‐to‐lymphocyte ratio predicts response to corticosteroids and is associated with infection and renal dysfunction in alcoholic hepatitis EH Forrest, N Storey, R Sinha, SR Atkinson, N Vergis, P Richardson, ... Alimentary pharmacology & therapeutics 50 (4), 442-453, 2019 | 68 | 2019 |
| Genome‐wide Association Study and Meta‐analysis on Alcohol‐Associated Liver Cirrhosis Identifies Genetic Risk Factors TH Schwantes‐An, R Darlay, P Mathurin, S Masson, S Liangpunsakul, ... Hepatology 73 (5), 1920-1931, 2021 | 63 | 2021 |
| Clinical but not histological factors predict long‐term prognosis in patients with histologically advanced non‐decompensated alcoholic liver disease S Masson, I Emmerson, E Henderson, EH Fletcher, AD Burt, CP Day, ... Liver International 34 (2), 235-242, 2014 | 49 | 2014 |
| White cell count and platelet count associate with histological alcoholic hepatitis in jaundiced harmful drinkers T Hardy, C Wells, S Kendrick, M Hudson, CP Day, AD Burt, S Masson, ... BMC gastroenterology 13 (1), 55, 2013 | 46 | 2013 |
| SARS‐CoV‐2 infections among patients with liver disease and liver transplantation who received COVID‐19 vaccination AM Moon, GJ Webb, I García‐Juárez, AV Kulkarni, G Adali, DK Wong, ... Hepatology communications 6 (4), 889-897, 2022 | 45 | 2022 |
